Compositions and Methods for Decolonizing Antibiotic-Resistant Bacteria in the Gut
Summary
The European Patent Office published patent application EP3665181A1 for Finch Therapeutics' compositions and methods for decolonizing antibiotic-resistant bacteria in the gut. The patent covers therapeutic compositions and methods of use targeting antibiotic-resistant bacterial colonization. The application was filed with claims across 39 designated European states.
What changed
The EPO published EP3665181A1, a patent application by Finch Therapeutics, Inc. covering compositions and methods for decolonizing antibiotic-resistant bacteria in the gastrointestinal tract. The patent includes claims under multiple IPC classifications including C07K (peptides), A61K (pharmaceutical preparations), and A61P (therapeutic activity). Inventors listed are Marina Santiago and Kevin Roelofs. The application designates 39 European states including major markets DE, FR, GB, IT, ES, NL, and CH.
Healthcare providers and pharmaceutical companies developing microbiome-based therapeutics should review this patent landscape to identify potential licensing needs or freedom-to-operate concerns. Intellectual property professionals should conduct clearance searches for similar composition claims. The patent provides Finch Therapeutics with exclusive rights to its decolonization technology across designated EPO member states upon grant.
What to do next
- Review patent claims for potential freedom-to-operate concerns if developing similar microbiome therapeutics
- Conduct landscape analysis for competing patents in gut decolonization technology
- Monitor patent prosecution for scope changes during examination
Source document (simplified)
COMPOSITIONS AND METHODS FOR DECOLONIZING ANTIBOTIC-RESISTANT BACTERIA IN THE GUT
Publication EP3665181A1 Kind: A1 Mar 25, 2026
Applicants
Finch Therapeutics, Inc.
Inventors
SANTIAGO, Marina, ROELOFS, Kevin
IPC Classifications
C07H 21/02 20060101AFI20210503BHEP C07H 21/04 20060101ALI20210503BHEP C07K 14/25 20060101ALI20210503BHEP C12P 19/34 20060101ALI20210503BHEP A61K 35/74 20150101ALI20210503BHEP A61P 1/00 20060101ALI20210503BHEP A61P 1/04 20060101ALI20210503BHEP A61P 31/04 20060101ALI20210503BHEP C12R 1/01 20060101ALI20210503BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.